Comparative Bioavailability of a Novel Fixed-dose Combination Etoricoxib and Tramadol.

Autor: Garza-Ocañas L; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Badillo-Castaneda CT; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Eguía SLM; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Zanatta-Calderón MT; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Garza JDT; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Gómez-Meza MV; Pharmacology and Toxicology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico., Sander-Padilla JG; Research and Development Department, Laboratorios Silanes S.A. de C.V, Mexico City, 11000, Mexico., Lugo-Sánchez LA; Research and Development Department, Laboratorios Silanes S.A. de C.V, Mexico City, 11000, Mexico., Rios-Brito KF; Research and Development Department, Laboratorios Silanes S.A. de C.V, Mexico City, 11000, Mexico., Romero-Antonio Y; Research and Development Department, Laboratorios Silanes S.A. de C.V, Mexico City, 11000, Mexico., González-Canudas J; Research and Development Department, Laboratorios Silanes S.A. de C.V, Mexico City, 11000, Mexico.; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.

Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Nov; Vol. 13 (11), pp. 1253-1259. Date of Electronic Publication: 2024 Jul 31.